Prescription medication · Selective Norepinephrine Reuptake Inhibitor

atomoxetine

Also sold as Strattera. Atomoxetine is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD).

Data updated 2026-05-15

3,228
FDA reportsLightly reported
15
InteractionsSeveral interactions
97% less
Generic vs brandHuge savings
6
Recall records

What the data shows

atomoxetine (Strattera) is a prescription Selective Norepinephrine Reuptake Inhibitor, among the least-reported drugs the FDA tracks (3,228 FDA reports), whose generic costs a fraction of the brand (about 97% less).

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

atomoxetine (Strattera) is a prescription Selective Norepinephrine Reuptake Inhibitor. Atomoxetine is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD).

Atomoxetine (Strattera) is a medicine that can help people with Attention-Deficit/Hyperactivity Disorder (ADHD). It works by affecting a chemical in the brain called norepinephrine.

Drug Pricing (NADAC)

Brand Price

$12.67/unit

Generic Price

$0.38/unit

Generic Savings

97%

Generic Available

Yes (8 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: ATOMOXETINE HCL 10 MG CAPSULE

Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: -7.5% vs prior release.

Effective NADAC / unit vs prior NDCs
October 23, 2024 $0.4095/EA - 1
December 18, 2024 $0.3786/EA -7.5% 7
Compare with Another Drug → Full Side Effects Report →

What it does

Atomoxetine is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD).

Common side effects

Feeling sick to your stomach, Throwing up, Feeling tired

Key warnings

Atomoxetine can increase the risk of suicidal thoughts in children and teenagers.

The sections below are summarized in plain English from atomoxetine's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Atomoxetine works by increasing the amount of norepinephrine in your brain. Norepinephrine is a chemical that helps you pay attention and control your impulses. By increasing norepinephrine, atomoxetine can improve ADHD symptoms.

Side Effects (from patient reports)

Based on 3,228 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for atomoxetine, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for atomoxetine each year to the FDA Adverse Event Reporting System (FAERS).

0200400600800 20042007201120142017202020232025 645

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where atomoxetine sits

atomoxetine has more FDA adverse-event reports than 19% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is atomoxetine; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 3,228 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

3,228

Reports Mentioning Death

879

27.2% of reports — not proof of cause

Hospitalization Reports

1,203

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 1,553 (57%)
Male 1,064 (39%)

Age Distribution

0–17 582
18–44 1,400
45–64 237
65–74 56
75+ 25

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
3 NAUSEA 431
5 HEADACHE 407
6 FATIGUE 401
7 CONDITION AGGRAVATED 395
8 HYPERTENSION 388
9 INSOMNIA 381
10 VOMITING 381
11 PAIN 379
12 ARTHRALGIA 374
13 ABDOMINAL DISCOMFORT 367
14 HEPATIC ENZYME INCREASED 367
15 HYPOAESTHESIA 360
16 ABDOMINAL PAIN UPPER 350
17 ALOPECIA 350
18 GENERAL PHYSICAL HEALTH DETERIORATION 350

Reactions in Death Reports

ARTHRALGIA 327
GLOSSODYNIA 325
HYPERTENSION 325
GENERAL PHYSICAL HEALTH DETERIORATION 324
HEPATIC ENZYME INCREASED 324
ABDOMINAL DISCOMFORT 319
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 317
BLOOD CHOLESTEROL INCREASED 317
ALOPECIA 314
ARTHROPATHY 314

Reactions in Hospitalization Reports

CONDITION AGGRAVATED 317
HYPERTENSION 311
HEPATIC ENZYME INCREASED 308
HEADACHE 303
ARTHRALGIA 300
BLOOD CHOLESTEROL INCREASED 299
ABDOMINAL DISCOMFORT 298
ALOPECIA 295
GENERAL PHYSICAL HEALTH DETERIORATION 295
GLOSSODYNIA 294

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Atomoxetine can increase the risk of suicidal thoughts in children and teenagers. Watch carefully for worsening mood or any unusual changes in behavior. Tell your doctor right away if you have any suicidal thoughts or feelings.

Known Drug Interactions

moderate albuterol

( 7.3 ) • Albuterol (or other beta 2 agonists) - Action of albuterol on cardiovascular system can be potentiated. 7.4 Albuterol Atomoxetine should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other beta 2 agonists) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure. Albuterol (600 mcg iv over 2 hours) induced increases in heart rate and blood pressure.

Mechanism: Atomoxetine can make the effects of albuterol on your heart and blood vessels much stronger. This can cause your heart to beat faster and your blood pressure to rise.

7.9 Drugs that Affect Gastric pH Drugs that elevate gastric pH (magnesium hydroxide/aluminum hydroxide, omeprazole) had no effect on atomoxetine bioavailability.

Mechanism: Omeprazole changes the acid levels in the stomach, but this does not change how the body absorbs atomoxetine.

7.2 Effect of CYP2D6 Inhibitors on Atomoxetine In extensive metabolizers (EMs), inhibitors of CYP2D6 (e.g., paroxetine, fluoxetine, and quinidine) increase atomoxetine steady-state plasma concentrations to exposures similar to those observed in poor metabolizers (PMs). In EM individuals treated with paroxetine or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and C ss, max is about 3- to 4-fold greater than atomoxetine alone.

Mechanism: Fluoxetine blocks the liver enzyme that breaks down atomoxetine, which causes the levels of atomoxetine in your blood to rise significantly.

7.7 Methylphenidate Coadministration of methylphenidate with atomoxetine did not increase cardiovascular effects beyond those seen with methylphenidate alone.

Mechanism: Taking these two drugs together does not seem to cause extra stress on the heart compared to taking methylphenidate by itself.

Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.

Mechanism: Atomoxetine does not interfere with how warfarin attaches to proteins in the blood, so it should not change how well the blood thinner works.

Check all your medications →

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I open the capsule and sprinkle it on food?
No, swallow the capsule whole. Do not open, crush, or chew it.
Can I stop taking atomoxetine suddenly?
You can stop taking atomoxetine without slowly decreasing the dose.
Will atomoxetine cure my ADHD?
Atomoxetine will not cure ADHD, but it can help manage your symptoms.
How long does it take for atomoxetine to work?
It may take several weeks for atomoxetine to start working.
Can atomoxetine affect my heart?
Atomoxetine can increase blood pressure and heart rate. Your doctor should check your heart before you start taking it.
Can atomoxetine cause liver problems?
In rare cases, atomoxetine can cause liver problems. Tell your doctor right away if you have yellowing of the skin or eyes, dark urine, or stomach pain.
Can atomoxetine affect my growth?
Atomoxetine can slow down growth in children. Your doctor should monitor your height and weight.
Can I drink alcohol while taking atomoxetine?
It is best to avoid alcohol while taking atomoxetine.
What should I do if I think I'm having a side effect?
Tell your doctor about any side effects you have while taking atomoxetine.
Can I take atomoxetine if I have glaucoma?
You should not take atomoxetine if you have narrow-angle glaucoma.
What are the common side effects of atomoxetine?
The registry lists Feeling sick to your stomach, Throwing up, Feeling tired, Not feeling hungry, Belly pain among the most-reported FAERS reaction terms for atomoxetine. The compiled record contains 3,228 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does atomoxetine interact with other medications?
The registry has 15 documented interaction rows for atomoxetine. Notable source-record pairings include albuterol, omeprazole, fluoxetine. These rows are not a complete medication review.
What drug class is atomoxetine?
atomoxetine belongs to the Selective Norepinephrine Reuptake Inhibitor drug class. It requires a prescription (Rx). Atomoxetine is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD).
Is there a generic version of atomoxetine?
Yes, generic atomoxetine is available from 8 manufacturers. The generic costs $0.38 per unit compared to $12.67 for the brand version, saving approximately 97%. Pricing is based on NADAC (National Average Drug Acquisition Cost) data from CMS.
What pregnancy or breastfeeding source fields are listed for atomoxetine?
The FDA label for atomoxetine contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Has atomoxetine been recalled?
There are 6 recalls associated with atomoxetine products. Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule. Check the recalls section below for full details and affected products.

Active Recalls

Class II April 30, 2026

Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.

Safecor Health, LLC

Class II January 29, 2025

CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Class II January 29, 2025

CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Class II January 29, 2025

CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Class II January 29, 2025

CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Class II January 29, 2025

CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.

Glenmark Pharmaceuticals Inc., USA

Other drugs grouped near atomoxetine - same-class peers and common alternatives.

Compare atomoxetine vs acamprosate side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for atomoxetine: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on atomoxetine

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for atomoxetine

The FDA label for atomoxetine (sold under brand names such as Strattera) classifies it as a prescription-only medication in the Selective Norepinephrine Reuptake Inhibitor class. Atomoxetine is used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Official labeling lists 11 commonly reported side effects, including Feeling sick to your stomach, Throwing up, Feeling tired.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 3,228 voluntary reports. The database also lists 15 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.38 versus $12.67 for the brand - a 97% generic savings.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 6 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: November 1, 2023

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page